|Dr. Andreas Eckert Ph.D.||Chairman of Exec. Board & CEO||340.75k||N/A||1960|
|Dr. Harald Hasselmann||Head of Radiation Therapy Segment & Member of the Exec. Board - Medical Segment||258.56k||N/A||1967|
|Dr. Lutz Helmke||Member of Exec. Board - Medical Segment||254.19k||N/A||1961|
|Dr. Gunnar Mann||Head of Intragroup Services||N/A||N/A||1967|
|Mr. Franklin B. Yeager||Pres of Eckert & Ziegler Isotope Products Inc.||N/A||N/A||N/A|
|Mr. Joseph Hathcock||VP of Eckert & Ziegler Isotope Products Inc||N/A||N/A||N/A|
|Ivan Simmer||Managing Director of Eckert & Ziegler Cesio s.r.o.||N/A||N/A||N/A|
|Ms. Claudia Goulart||MD - Eckert & Ziegler Brasil Participacoes, Comericial & Logistica Ltda.||N/A||N/A||N/A|
Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.
Eckert & Ziegler Strahlen- und Medizintechnik AG’s ISS Governance QualityScore as of October 1, 2022 is 9. The pillar scores are Audit: 9; Board: 9; Shareholder Rights: 1; Compensation: 9.